28241859|t|Human amnion epithelial cells rescue cell death via immunomodulation of microglia in a mouse model of perinatal brain injury
28241859|a|Human amnion epithelial cells (hAECs) are clonogenic and have been proposed to reduce inflammatory - induced tissue injury. Perturbation of the immune response is implicated in the pathogenesis of perinatal brain injury; modulating this response could thus be a novel therapy for treating or preventing such injury. The immunomodulatory properties of hAECs have been shown in other animal models, but a detailed investigation of the effects on brain immune cells following injury has not been undertaken. Here, we investigate the effects of hAECs on microglia, the first immune responders to injury within the brain. We generated a mouse model combining neonatal inflammation and perinatal hyperoxia, both of which are risk factors associated with perinatal brain injury. On embryonic day 16 we administered lipopolysaccharide (LPS), or saline (control), intra-amniotically to C57Bl/6 J mouse pups. On postnatal day (P)0, LPS pups were placed in hyperoxia (65% oxygen) and control pups in normoxia for 14 days. Pups were given either hAECs or saline intravenously on P4. At P14, relative to controls, LPS and hyperoxia pups had reduced body weight, increased density of apoptotic cells (TUNEL) in the cortex, striatum and white matter, astrocytes (GFAP) in the white matter and activated microglia (CD68) in the cortex and striatum, but no change in total microglia density (Iba1). hAEC administration rescued the decreased body weight and reduced apoptosis and astrocyte areal coverage in the white matter, but increased the density of total and activated microglia. We then stimulated primary microglia (CD45 (low) CD11b (+)) with LPS for 24 h, followed by co-culture with hAEC conditioned medium for 48 h. hAEC conditioned medium increased microglial phagocytic activity, decreased microglia apoptosis and decreased M1 activation markers (CD86). Stimulating hAECs for 24 h with LPS did not alter release of cytokines known to modulate microglia activity. These data demonstrate that hAECs can directly immunomodulate brain microglia, probably via release of trophic factors. This observation offers promise that hAECs may afford therapeutic utility in the management of perinatal brain injury.
28241859	0	5	Human	T016	C0086418
28241859	6	12	amnion	T018	C1305379
28241859	13	29	epithelial cells	T025	C0014597
28241859	37	47	cell death	T043	C0007587
28241859	52	68	immunomodulation	T061	C1963758
28241859	72	81	microglia	T025	C0206116
28241859	87	98	mouse model	T050	C2986594
28241859	102	124	perinatal brain injury	T037	C2347482
28241859	125	130	Human	T016	C0086418
28241859	131	137	amnion	T018	C1305379
28241859	138	154	epithelial cells	T025	C0014597
28241859	156	161	hAECs	T025	C0014597
28241859	167	177	clonogenic	T081	C0392762
28241859	204	210	reduce	T081	C0205216
28241859	211	223	inflammatory	T046	C0021368
28241859	226	233	induced	T169	C0205263
28241859	234	247	tissue injury	T037	C0037578
28241859	249	261	Perturbation	T169	C0332453
28241859	269	284	immune response	T042	C0301872
28241859	306	318	pathogenesis	T046	C0699748
28241859	322	344	perinatal brain injury	T037	C2347482
28241859	346	356	modulating	T082	C0443264
28241859	362	370	response	T042	C0301872
28241859	387	392	novel	T080	C0205314
28241859	393	400	therapy	T061	C0087111
28241859	405	413	treating	T169	C1522326
28241859	433	439	injury	T037	C2347482
28241859	445	461	immunomodulatory	T061	C1963758
28241859	476	481	hAECs	T025	C0014597
28241859	507	520	animal models	T008	C0599779
28241859	537	550	investigation	T058	C0220825
28241859	558	565	effects	T080	C1280500
28241859	569	574	brain	T023	C0006104
28241859	575	581	immune	T169	C0439662
28241859	582	587	cells	T025	C0007634
28241859	598	604	injury	T037	C2347482
28241859	639	650	investigate	T058	C0220825
28241859	655	662	effects	T080	C1280500
28241859	666	671	hAECs	T025	C0014597
28241859	675	684	microglia	T025	C0206116
28241859	696	713	immune responders	T042	C0301872
28241859	717	723	injury	T037	C2347482
28241859	735	740	brain	T023	C0006104
28241859	757	768	mouse model	T050	C2986594
28241859	779	787	neonatal	T079	C2939425
28241859	788	800	inflammation	T046	C0021368
28241859	805	814	perinatal	T079	C0178795
28241859	815	824	hyperoxia	T184	C0242706
28241859	844	856	risk factors	T033	C0035648
28241859	873	895	perinatal brain injury	T037	C2347482
28241859	900	909	embryonic	T042	C0013936
28241859	910	913	day	T079	C0439228
28241859	920	932	administered	T061	C1533734
28241859	933	951	lipopolysaccharide	T109	C0023810
28241859	953	956	LPS	T109	C0023810
28241859	962	968	saline	T167	C0036082
28241859	970	977	control	T167	C1550141
28241859	980	998	intra-amniotically	T169	C1512912
28241859	1002	1022	C57Bl/6 J mouse pups	T015	C1521751
28241859	1027	1036	postnatal	T079	C0443281
28241859	1037	1040	day	T079	C0439228
28241859	1047	1050	LPS	T109	C0023810
28241859	1051	1055	pups	T015	C1521751
28241859	1071	1080	hyperoxia	T184	C0242706
28241859	1086	1092	oxygen	T121,T123,T196	C0030054
28241859	1098	1110	control pups	T096	C0009932
28241859	1114	1122	normoxia	T070	C0311411
28241859	1130	1134	days	T079	C0439228
28241859	1136	1140	Pups	T015	C1521751
28241859	1159	1164	hAECs	T025	C0014597
28241859	1168	1174	saline	T167	C0036082
28241859	1175	1188	intravenously	T061	C1737200
28241859	1216	1224	controls	T096	C0009932
28241859	1226	1229	LPS	T109	C0023810
28241859	1234	1243	hyperoxia	T184	C0242706
28241859	1244	1248	pups	T015	C1521751
28241859	1253	1260	reduced	T081	C0205216
28241859	1261	1272	body weight	T032	C0005910
28241859	1274	1283	increased	T081	C0205217
28241859	1284	1291	density	T081	C0178587
28241859	1295	1304	apoptotic	T080	C1516044
28241859	1305	1310	cells	T025	C0007634
28241859	1312	1317	TUNEL	T063	C1515232
28241859	1326	1332	cortex	T023	C0007776
28241859	1334	1342	striatum	T023	C0010097
28241859	1347	1359	white matter	T024	C0682708
28241859	1361	1371	astrocytes	T025	C0004112
28241859	1373	1377	GFAP	T116,T123	C0017626
28241859	1386	1398	white matter	T024	C0682708
28241859	1403	1412	activated	T169	C1515877
28241859	1413	1422	microglia	T025	C0206116
28241859	1424	1428	CD68	T116,T129	C0215872
28241859	1437	1443	cortex	T023	C0007776
28241859	1448	1456	striatum	T023	C0010097
28241859	1481	1490	microglia	T025	C0206116
28241859	1491	1498	density	T081	C0178587
28241859	1500	1504	Iba1	T116,T129	C0312586
28241859	1507	1511	hAEC	T025	C0014597
28241859	1512	1526	administration	T061	C1533734
28241859	1539	1548	decreased	T081	C0205216
28241859	1549	1560	body weight	T032	C0005910
28241859	1565	1572	reduced	T081	C0205216
28241859	1573	1582	apoptosis	T043	C0162638
28241859	1587	1596	astrocyte	T025	C0004112
28241859	1597	1611	areal coverage	T169	C1999244
28241859	1619	1631	white matter	T024	C0682708
28241859	1637	1646	increased	T081	C0205217
28241859	1651	1658	density	T081	C0178587
28241859	1672	1681	activated	T169	C1515877
28241859	1682	1691	microglia	T025	C0206116
28241859	1712	1719	primary	T080	C0205225
28241859	1720	1729	microglia	T025	C0206116
28241859	1731	1735	CD45	T116,T123	C1435882
28241859	1742	1747	CD11b	T116,T129,T192	C1136310
28241859	1758	1761	LPS	T109	C0023810
28241859	1784	1794	co-culture	T059	C0282547
28241859	1800	1804	hAEC	T025	C0014597
28241859	1805	1823	conditioned medium	T130	C0162518
28241859	1834	1838	hAEC	T025	C0014597
28241859	1839	1857	conditioned medium	T130	C0162518
28241859	1858	1867	increased	T081	C0205217
28241859	1868	1878	microglial	T025	C0206116
28241859	1879	1898	phagocytic activity	T043	C0031308
28241859	1900	1909	decreased	T081	C0205216
28241859	1910	1919	microglia	T025	C0206116
28241859	1920	1929	apoptosis	T043	C0162638
28241859	1934	1943	decreased	T081	C0205216
28241859	1944	1965	M1 activation markers	T043	C0024426
28241859	1967	1971	CD86	T116,T129	C1528561
28241859	1986	1991	hAECs	T025	C0014597
28241859	2006	2009	LPS	T109	C0023810
28241859	2024	2031	release	T061	C1963578
28241859	2035	2044	cytokines	T116,T129	C0079189
28241859	2054	2062	modulate	T082	C0443264
28241859	2063	2072	microglia	T025	C0206116
28241859	2073	2081	activity	T052	C0441655
28241859	2089	2093	data	T078	C1511726
28241859	2111	2116	hAECs	T025	C0014597
28241859	2130	2144	immunomodulate	T061	C1963758
28241859	2145	2150	brain	T023	C0006104
28241859	2151	2160	microglia	T025	C0206116
28241859	2175	2182	release	T061	C1963578
28241859	2186	2201	trophic factors	T116,T123	C1579754
28241859	2208	2219	observation	T062	C0302523
28241859	2240	2245	hAECs	T025	C0014597
28241859	2257	2276	therapeutic utility	T061	C0087111
28241859	2284	2294	management	T058	C0376636
28241859	2298	2320	perinatal brain injury	T037	C2347482